Delayed discharges due to initiation of warfarin in atrial fibrillation: A prospective audit

American Journal Geriatric Pharmacotherapy

Volumn 5, Issue 3, 2007, Pages 232-235

  Tan, Evelyn S ^a   Bonnett, Tessa J ^a   Abdelhafiz, Ahmed H ^a  

^a ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

anticoagulation; atrial fibrillation; hospital; warfarin

Indexed keywords

WARFARIN;

ADULT; AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARTHEL INDEX; BLEEDING; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DRUG DOSE COMPARISON; ELDERLY CARE; FEMALE; GENERAL HOSPITAL; HEART ATRIUM FIBRILLATION; HOSPITAL CARE; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; LOADING DRUG DOSE; MALE; MEDICAL AUDIT; OUTPATIENT CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX DIFFERENCE;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; FEMALE; HOSPITALS, DISTRICT; HOSPITALS, GENERAL; HUMANS; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; MALE; MEDICAL AUDIT; MIDDLE AGED; PROSPECTIVE STUDIES; WARFARIN;

EID: 35848966098     PISSN: 15435946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjopharm.2007.10.006     Document Type: Article

References (13)

1. Singer D., Albers G., Dalen J., et al. Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl 3 (2004) 429S-456S
2. Freestone B., and Lip G. Epidemiology and costs of cardiac arrhythmias. In: Lip G., and Godtfredsen J. (Eds). Cardiac Arrhythmias: A Clinical Approach (2003), Mosby, Edinburgh, Scotland 3-24
3. Wattigney W., Mensah G., and Croft J. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: Implications for primary prevention. Circulation 108 (2003) 711-716
4. Stewart S., Murphy N., Walker A., et al. Cost of an emerging epidemic: An economic analysis of atrial fibrillation in the UK. Heart 90 (2004) 286-292
5. Hart R., Benavente O., McBride R., and Pearce L. Anti-thrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 131 (1999) 492-501
6. Ansell J., Hirsh J., Poller L., et al. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. [published correction appears in Chest. 2005;127:415-416]. Chest 126 Suppl 3 (2004) 204S-233S
7. Fuster V., Ryden L., Cannom D., et al. ACC/AHA/ ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation). J Am Coll Cardiol 48 (2006) e149-e246
8. Mahoney F., and Barthel D. Functional evaluation: The Barthel Index. Md State Med J 14 (1965) 61-65
9. National Audit Office (NAO) [NAO Web site]. Inpatient admissions and bed management in NHS acute hospitals.
10. Available at:. http://www.nao.org.uk/publications/nao_reports/9900254.pdf Accessed November 6, 2006
11. Oates A., Jackson P., Austin C., and Channer K. A new regimen for starting warfarin therapy in out-patients. Br J Clin Pharmacol 46 (1998) 157-161
12. Janes S., Challis R., and Fisher F. Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR. Clin Lab Haematol 26 (2004) 43-47
13. Fitzmaurice D., Murray E., McCahon D., et al. Self management of oral anticoagulation: Randomised trial. [published correction appears in BMJ. 2005;331:1330]. BMJ 331 (2005) 1057